HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Articles by ZÁRATE, A. Articles by FERNÁNDEZ-LAZALA, R. Search for Related Content PubMed PubMed Citation Articles by ZÁRATE, A. Articles by FERNÁNDEZ-LAZALA, R.

Bromocriptine

Clinical Experience in the Induction of Pregnancy in Amenorrhea- Galactorrhea Syndrome

From the Department of Endocrinology. Hospital de Gineco-Obstetricia No. Uno. and the Department of Reproductive Biology, Instituto Mexicano del Seguro Social, Mexico

Abstract

This study included a group of 50 women with amenorrheagalactorrhea who were treated with bromocriptine (2-bromo-- ergocryptine). Forty-two of these patients ovulated, and 36 conceived within 8 months of treatment. The pregnancies of 30 women reached a duration of 20 weeks or longer following ovulation induced by bromocriptine. Except in 1 case which ended in a 10-week spontaneous abortion, the pregnancies of 26 patients terminated in 24 single, one twin, and one triplet births. All of the 29 newborns were healthy, and no congenital malformations were detected. The main side effects during treatment were transient constipation and nausea. Following delivery, return to pretreatment status was noted in all patients, which supports the fact that bromocriptine is not a curative agent.